[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  ZhaoSonsWealth [@ZhaoSonsWealth](/creator/twitter/ZhaoSonsWealth) on x XX followers Created: 2025-07-20 17:55:30 UTC GLMD has more clinical value than XX% of the biotech runners this year — and it’s still trading like nobody sees it. $TRKA $MULN $FNGR $PHUN $COSM $BBIG $NAKD $WLDS $DUO $SNTI $AVTX $UCAR $CRKN $TOP $XELA $TBLT $LOCL $MDVL $RETO $VEEE XXX engagements  **Related Topics** [$veee](/topic/$veee) [$reto](/topic/$reto) [$mdvl](/topic/$mdvl) [$locl](/topic/$locl) [$tblt](/topic/$tblt) [$xela](/topic/$xela) [$crkn](/topic/$crkn) [$ucar](/topic/$ucar) [Post Link](https://x.com/ZhaoSonsWealth/status/1946992378029781210)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
ZhaoSonsWealth @ZhaoSonsWealth on x XX followers
Created: 2025-07-20 17:55:30 UTC
GLMD has more clinical value than XX% of the biotech runners this year — and it’s still trading like nobody sees it. $TRKA $MULN $FNGR $PHUN $COSM $BBIG $NAKD $WLDS $DUO $SNTI $AVTX $UCAR $CRKN $TOP $XELA $TBLT $LOCL $MDVL $RETO $VEEE
XXX engagements
Related Topics $veee $reto $mdvl $locl $tblt $xela $crkn $ucar
/post/tweet::1946992378029781210